7.51

0.27% 0.02

Lifestance Health Group Inc (LFST)

Overview News Price History Option Chain Financials Why LFST Down? Discussions Forecast

Lifestance Health Group Inc stock is traded at $7.51, with a volume of 1.28M. It is up +0.27% in the last 24 hours and up +9.64% over the past month. LifeStance Health Group Inc is a mental healthcare company focused on providing evidence-based, medically driven treatment services for children, adolescents, and adults suffering from a variety of mental health issues in an outpatient care setting, both in-person and through its digital health telemedicine offering.

Previous Close:

$7.49

Open:

$7.55

24h Volume:

1.28M

Relative Volume:

0.84

Market Cap:

$2.86B

Revenue:

$1.16B

Net Income/Loss:

$-150.92M

P/E Ratio:

-16.33

EPS:

-0.46

Net Cash Flow:

$-17.76M

1W Performance:

+4.02%

1M Performance:

+9.64%

6M Performance:

+31.75%

1Y Performance:

+13.62%

1-Day Range:

$7.455

$7.59

1-Week Range:

$7.175

$7.73

52-Week Range:

$4.64

$9.20

Lifestance Health Group Inc Stock (LFST) Company Profile

Name

Lifestance Health Group Inc

Sector

Healthcare (1200)

Industry

Medical Care Facilities (53)

Phone

602-767-2100

Address

4800 N. SCOTTSDALE ROAD, SCOTTSDALE

Employee

7,269

Twitter

Next Earnings Date

2024-11-07

Latest SEC Filings

LFST's Discussions on Twitter

Compare LFST with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
LFST Lifestance Health Group Inc	7.51	2.86B	1.16B	-150.92M	-17.76M	-0.46
HCA Hca Healthcare Inc	325.47	83.32B	69.62B	5.93B	5.88B	20.33
THC Tenet Healthcare Corp	141.98	13.97B	20.97B	3.13B	2.39B	4.33
DVA Davita Inc	165.63	13.81B	12.67B	827.68M	1.42B	5.03
UHS Universal Health Services Inc	203.50	13.34B	15.42B	1.03B	956.84M	9.53
FMS Fresenius Medical Care Ag Adr	22.48	13.16B	20.87B	715.14M	1.67B	0.8156

Lifestance Health Group Inc Stock (LFST) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-03-24	Initiated	Barclays	Underweight
May-15-23	Downgrade	TD Cowen	Outperform → Market Perform
Jan-06-23	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Nov-07-22	Resumed	Jefferies	Buy
Mar-17-22	Downgrade	UBS	Buy → Neutral
Nov-09-21	Downgrade	JP Morgan	Overweight → Neutral
Sep-10-21	Initiated	Cowen	Outperform
Aug-16-21	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Jul-06-21	Initiated	Goldman	Neutral
Jul-06-21	Initiated	JP Morgan	Overweight
Jul-06-21	Initiated	Jefferies	Buy
Jul-06-21	Initiated	Morgan Stanley	Overweight
Jul-06-21	Initiated	William Blair	Outperform

View All

Lifestance Health Group Inc Stock (LFST) Latest News

Nov 23, 2024

Jennison Associates LLC Purchases 184,896 Shares of LifeStance Health Group, Inc. (NASDAQ:LFST) - MarketBeat

Nov 23, 2024

Nov 22, 2024

Landscape Capital Management L.L.C. Grows Stock Position in LifeStance Health Group, Inc. (NASDAQ:LFST) - MarketBeat

Nov 22, 2024

Nov 17, 2024

When (LFST) Moves Investors should Listen - Stock Traders Daily

Nov 17, 2024

Nov 15, 2024

LifeStance to Host Fourth Quarter and Full Year 2022 Earnings Conference Call on March 8, 2023 - Quantisnow

Nov 15, 2024

Nov 13, 2024

Lifestance Health's SWOT analysis: stock valuation concerns amid strong performance - Investing.com India

Nov 13, 2024

Principal Financial Group Inc. Acquires 235,316 Shares of LifeStance Health Group, Inc. (NASDAQ:LFST) - MarketBeat

Nov 13, 2024

Nov 11, 2024

Barclays Forecasts Strong Price Appreciation for LifeStance Health Group (NASDAQ:LFST) Stock - MarketBeat

Nov 11, 2024

William Blair Has Positive Forecast for LFST FY2024 Earnings - MarketBeat

Nov 11, 2024

Nov 09, 2024

LifeStance Health Group (NASDAQ:LFST) Posts Quarterly Earnings Results, Beats Expectations By $0.05 EPS - MarketBeat

Nov 09, 2024

Nov 08, 2024

Lifestance Health Shares Rise After Q3 Beat, 2024 Revenue Outlook Lifted - Marketscreener.com

Nov 07, 2024

LifeStance Health Group, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 07, 2024

LifeStance Reports Third Quarter 2024 Results - StockTitan

Nov 07, 2024

Nov 06, 2024